Genism, Racism, and the Prospect of Genetic Genocide
By George J. Annas
| 09. 03. 2001
Prepared for presentation at UNESCO 21st Century Talks: The New Aspects of Racism in the Age of Globalization and the Gene Revolution at the World Conference against Racism, Racial Discrimination, Xenophobia and Related Intolerance, Durban, South Africa
I greatly appreciate the opportunity to speak to you on the topic of "Genism, Racism, and the Prospect of Genetic Genocide" in conjunction with the World Conference against Racism. I think there is little doubt that the 21st century will be the century of human genetics. New genetic technologies have the potential not only to change what we can do to ourselves and each other, but more importantly, to change the very way we see ourselves and each other.
Our superficial perceptions of each other have often fostered racism in the past. Simply defined, racism is "the theory that distinctive human characteristics and abilities are determined by race." The hunt for genes, especially in groups identified by racial classifications, could lead to "genism" (a term not yet officially recognized, but one I would define as the theory that distinctive human characteristics and abililites are determined by genes) based on DNA sequence characteristics with resulting discrimination as pernicious as racism.
A second consequence of the new genetics will be a temptation to use our new powers to transform ourselves by attempting...
Related Articles
By Neel Shah, The PrePrint | 04.11.2024
Years ago, I interviewed for a residency position at The Johns Hopkins Hospital in Baltimore. Standing before the domed Victorian building at the campus entrance, I couldn’t help but be in awe of the history of the place, the great...
By Rob Stein, NPR | 03.07.2024
A big federal research project aimed at reducing racial disparities in genetic research has unveiled the program's first major trove of results.
"This is a huge deal," says Dr. Joshua Denny, who runs the All of Us program at...
By Max Kozlov, Nature | 02.23.2024
Some geneticists have expressed their unease about a figure in a high-profile Nature paper that was published earlier this week1, noting that it could be misinterpreted as reinforcing racist beliefs. The figure has reignited a long-standing debate among...
By Victoria Gray, Uduak Thomas, and Kevin Davies, The CRISPR Journal | 02.14.2024
In July 2019, medical staff in Nashville dosed the first U.S. patient in the exa-cel therapy trial, sponsored by Vertex Pharmaceuticals and CRISPR Therapeutics. That first patient was Victoria Gray, a mother of four from Forest, Mississippi, a sickle cell...
